Localized Electroporation With Dielectrophoretic Field Flow Fractionation: Toward Removal of Circulating Tumour Cells From Human Blood.

Abstract

This paper presents the design and experimental performance of a microelectrode-based device to selectively lyse cells in a flow in a microfluidic channel. Localized cell lysis is achieved by utilizing "irreversible electroporation," in which cells are exposed to high magnitude electric pulses. Localized cell lysis in a flow has research applications and may allow for the removal of harmful cells, such as circulating tumor cells from blood. Due to the dependence of this technique on the magnitude of the applied electric field, lethal electric field regions can be localized in the channel by the calibration of the applied voltage. Dielectrophoresis field flow fractionation is used to levitate target cancer cells in the lethal region of the device microchannel. Experiments are performed to demonstrate the localized lysis of MCF7 cancer cells in a mixture of blood cells. Due to their larger size, these circulating tumor cell analogues levitate to a greater height in the channel than erythrocytes. MCF7 lysis is observed to increase from 4.6% in control experiments to 57.3% in active experiments. Leukocyte viability was unaffected in active experiments. These results demonstrate the feasibility of localizing cell lysis in a microfluidic flow environment.